scholarly journals Dealing with disability: challenges in Dutch health care of parents with a non-Western migration background and a child with a developmental disability

2021 ◽  
pp. 1-12
Author(s):  
Martine Dijkstra ◽  
Els Rommes
Keyword(s):  
Health Care ◽  
Developmental Disability ◽  
Migration Background ◽  
Dutch Health ◽  
Dutch Health Care ◽  
Western Migration

scholarly journals Some pain, no gain: experiences with the no-claim rebate in the Dutch health care system

2009 ◽  
Vol 4 (4) ◽  
pp. 405-424 ◽  
Author(s):  
J. HOLLAND ◽  
N.J.A. VAN EXEL ◽  
F.T. SCHUT ◽  
W.B.F. BROUWER
Keyword(s):  
Health Care ◽  
Health Insurance ◽  
Health Care System ◽  
Social Health Insurance ◽  
Convenience Sample ◽  
High Loss ◽  
Dutch Health ◽  
Dutch Health Care ◽  
Gp Visits ◽  
Care System

AbstractTo contain expenditures in an increasingly demand driven health care system, in 2005 a no-claim rebate was introduced in the Dutch health insurance system. Since demand-side cost sharing is a very controversial issue, the no-claim rebate was launched as a consumer friendly bonus system to reward prudent utilization of health services. Internationally, the introduction of a mandatory no-claim rebate in a social health insurance scheme is unprecedented. Consumers were entitled to an annual rebate of ₠ 255 if no claims were made. During the year, all health care expenses except for GP visits and maternity care were deducted from the rebate until the rebate became zero. In this article, we discuss the rationale of the no-claim rebate and the available evidence of its effect. Using a questionnaire in a convenience sample, we examined people’s knowledge, attitudes, and sensitivity to the incentive scheme. We find that only 4% of respondents stated that they would reduce consumption because of the no-claim rebate. Respondents also indicated that they were willing to accept a high loss of rebate in order to use a medical treatment. However, during the last month of the year many respondents seemed willing to postpone consumption until the next year in order to keep the rebate of the current year intact. A small majority of respondents considered the no-claim rebate to be unfair. Finally, we briefly discuss why in 2008 the no-claim rebate was replaced by a mandatory deductible.

The Governance of Quality Management in Dutch Health Care

2013 ◽  
Vol 22 (3) ◽  
pp. 236-247 ◽  
Author(s):  
J. A. M. Maarse ◽  
D. Ruwaard ◽  
C. Spreeuwenberg
Keyword(s):  
Health Care ◽  
Quality Management ◽  
Dutch Health ◽  
Dutch Health Care

scholarly journals Evaluation of moral case deliberation at the Dutch Health Care Inspectorate: a pilot study

2016 ◽  
Vol 17 (1) ◽  
Author(s):  
Wike Seekles ◽  
Guy Widdershoven ◽  
Paul Robben ◽  
Gonny van Dalfsen ◽  
Bert Molewijk
Keyword(s):  
Health Care ◽  
Pilot Study ◽  
Moral Case Deliberation ◽  
Dutch Health ◽  
Dutch Health Care ◽  
Moral Case

Technology assessment, priority setting and appropriate care in Dutch health care

2004 ◽  
Vol 20 (4) ◽  
pp. 564-564 ◽  
Author(s):  
Marc Berg ◽  
Tom van der Grinten ◽  
Niek Klazinga
Keyword(s):  
Health Care ◽  
Decision Making ◽  
Comparative Analysis ◽  
Priority Setting ◽  
Technology Assessment ◽  
Economic Evaluations ◽  
Technol Assess Health ◽  
Appropriate Care ◽  
Dutch Health ◽  
Dutch Health Care

References 8, 29, and 32 are incorrect as they appear in the article entitled “Technology assessment, priority setting, and appropriate care in Dutch health care,” by Marc Berg, Tom van der Grinten, and Niek Klazinga (Int J Technol Assess Health Care. 2004;20[1]:35-43). They should appear as follows: 8. Burgers JS, Bailey JV, Klazinga NS, et al. Inside guidelines: comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 2002;11:1933-1939.29. Zwart-van Rijkom JE, Leufkens HG, Busschbach JJ, et al. Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project. Pharmacoeconomics 2000;2:149-160.32. Van der Grinten TED. Hervorming van de gezondheidszorg. Zal het deze keer wel lukken? Beleid & Maatschappij 2002;3:172-176.

scholarly journals Does managed competition constrain hospitals' contract prices? Evidence from the Netherlands

2019 ◽  
Vol 15 (3) ◽  
pp. 341-354 ◽  
Author(s):  
Rudy Douven ◽  
Monique Burger ◽  
Frederik Schut
Keyword(s):  
Health Care ◽  
Managed Competition ◽  
Policy Options ◽  
Price Variation ◽  
Price Adjustments ◽  
Dutch Health ◽  
Dutch Health Care ◽  
Hospital Payment ◽  
First Time ◽  
Cross Subsidization

AbstractIn the Dutch health care system, health insurers negotiate with hospitals about the pricing of hospital products in a managed competition framework. In this paper, we study these contract prices that became for the first time publicly available in 2016. The data show substantive price variation between hospitals for the same products, and within a hospital for the same product across insurers. About 27% of the contract prices for a hospital product are at least 20% higher or lower than the average contract price in the market. For about half of the products, the highest and the lowest contract prices across hospitals differ by a factor of three or more. Moreover, hospital product prices do not follow a consistent ranking across hospitals, suggesting substantial cross-subsidization between hospital products. Potential explanations for the large and seemingly random price variation are: (i) different cost pricing methods used by hospitals, (ii) uncertainty due to frequent changes in the hospital payment system, (iii) price adjustments related to negotiated lumpsum payments and (iv) differences in hospital and insurer market power. Several policy options are discussed to reduce variation and increase transparency of hospital prices.

Sign in / Sign up

Export Citation Format

Share Document